Liabilities and Equity in USD of Organon & Co. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Organon & Co. quarterly Liabilities and Equity history and change rate from Q4 2020 to Q3 2025.
  • Organon & Co. Liabilities and Equity for the quarter ending 30 Sep 2025 was $13.6B, a 6.27% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Organon & Co. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $13.6B +$800M +6.27% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $13.5B +$1.35B +11.1% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $13.2B +$1.27B +10.6% 31 Mar 2025 10-Q 02 May 2025
Q4 2024 $13.1B +$1.04B +8.65% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 $12.8B +$1.74B +15.8% 30 Sep 2024 10-Q 01 Nov 2024
Q2 2024 $12.2B +$1.18B +10.7% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $11.9B +$1.13B +10.5% 31 Mar 2024 10-Q 03 May 2024
Q4 2023 $12.1B +$1.1B +10.1% 31 Dec 2023 10-K/A 10 Nov 2025
Q3 2023 $11B +$575M +5.51% 30 Sep 2023 10-Q 03 Nov 2023
Q2 2023 $11B +$365M +3.44% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $10.8B +$166M +1.57% 31 Mar 2023 10-Q 05 May 2023
Q4 2022 $11B +$274M +2.57% 31 Dec 2022 10-K 26 Feb 2024
Q3 2022 $10.4B -$898M -7.92% 30 Sep 2022 10-Q 04 Nov 2022
Q2 2022 $10.6B -$294M -2.7% 30 Jun 2022 10-Q 05 Aug 2022
Q1 2022 $10.6B +$955M +9.91% 31 Mar 2022 10-Q 06 May 2022
Q4 2021 $10.7B +$572M +5.66% 31 Dec 2021 10-K 27 Feb 2023
Q3 2021 $11.3B 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $10.9B 30 Jun 2021 10-Q 16 Aug 2021
Q1 2021 $9.64B 31 Mar 2021 10-Q 21 Jun 2021
Q4 2020 $10.1B 31 Dec 2020 10-K 21 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.